Increased T-cell Reactivity and Elevated Levels of CD8+ Memory T-cells in Alzheimer’s Disease-patients and T-cell Hyporeactivity in an Alzheimer’s Disease-mouse Model: Implications for Immunotherapy (original) (raw)

References

• Adunsky, A., Baram, D., Hershkowitz, M., & Mekori, Y. A. (1991). Increased cytosolic free calcium in lymphocytes of Alzheimer patients. Journal of Neuroimmunology, 33, 167–172.
  PubMed CAS Google Scholar
• Adunsky, A., Diver-Haber, A., Becker, D., & Hershkowitz, M. (1995). Basal and activated intracellular calcium ion concentrations in mononuclear cells of Alzheimer’s disease and unipolar depression. The Journals of Gerontology. Series A Biological Sciences and Medical Sciences, 50, B201–B204.
  CAS Google Scholar
• Aloisi, F., Ria, F., Columba-Cabezas, S., Hess, H., Penna, G., & Adorini, L. (1999). Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation. European Journal of Immunology, 29, 2705–2714.
  PubMed CAS Google Scholar
• Blanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., Bayer, T. A., Langui, D., Duyckaerts, C., Tremp, G., & Pradier, L. (2003). Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Experimental Neurology, 184, 247–263.
  PubMed CAS Google Scholar
• Bongioanni, P., Boccardi, B., Borgna, M., Castagna, M., & Mondino, C. (1997a). T-cell interferon gamma binding in patients with dementia of the Alzheimer type. Archives of Neurology, 54, 457–462.
  PubMed CAS Google Scholar
• Bongioanni, P., Boccardi, B., Borgna, M., & Rossi, B. (1998). T-lymphocyte interleukin 6 receptor binding in patients with dementia of Alzheimer type. Archives of Neurology, 55, 1305–1308.
  PubMed CAS Google Scholar
• Bongioanni, P., Romano, M. R., Sposito, R., Castagna, M., Boccardi, B., & Borgna, M. (1997b). T-cell tumour necrosis factor-alpha receptor binding in demented patients. Journal of Neurology, 244, 418–425.
  PubMed CAS Google Scholar
• Carson, M. J., Reilly, C. R., Sutcliffe, J. G., & Lo, D. (1999). Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. American Journal of Pathology, 154, 481–494.
  PubMed CAS Google Scholar
• Carson, M. J., & Sutcliffe, J. G. (1999). Balancing function vs. self defense: The CNS as an active regulator of immune responses. Journal of Neuroscience Research, 55, 1–8.
  PubMed CAS Google Scholar
• Chandok, M. R., & Farber, D. L. (2004). Signaling control of memory T cell generation and function. Seminars in Immunology, 16, 285–293.
  PubMed CAS Google Scholar
• Chiodetti, L., Choi, S., Barber, D. L., & Schwartz, R. H. (2006). Adaptive tolerance and clonal anergy are distinct biochemical states. Journal of Immunology, 176, 2279–2291.
  CAS Google Scholar
• Cho, B. K., Wang, C., Sugawa, S., Eisen, H. N., & Chen, J. (1999). Functional differences between memory and naive CD8 T cells. Proceedings of the National Academy of Sciences of the United States of America, 96, 2976–2981.
  PubMed CAS Google Scholar
• Colton, C. A., Brown, C. M., & Vitek, M. P. (2005). Sex steroids, APOE genotype and the innate immune system. Neurobiology of Aging, 26, 363–372.
  PubMed CAS Google Scholar
• Cornet, A., Bettelli, E., Oukka, M., Cambouris, C., Avellana-Adalid, V., Kosmatopoulos, K., & Liblau, R. S. (2000). Role of astrocytes in antigen presentation and naive T-cell activation. Journal of Neuroimmunology, 106, 69–77.
  PubMed CAS Google Scholar
• Cribbs, D. H., Ghochikyan, A., Vasilevko, V., Tran, M., Petrushina, I., Sadzikava, N., Babikyan, D., Kesslak, P., Kieber-Emmons, T., Cotman, C. W., & Agadjanyan, M. G. (2003). Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. International Immunology, 15, 505–514.
  PubMed CAS Google Scholar
• Czech, C., Delaere, P., Macq, A. F., Reibaud, M., Dreisler, S., Touchet, N., Schombert, B., Mazadier, M., Mercken, L., Theisen, M., Pradier, L., Octave, J. N., Beyreuther, K., & Tremp, G. (1997). Proteolytical processing of mutated human amyloid precursor protein in transgenic mice. Brain Research. Molecular Brain Research, 47, 108–116.
  PubMed CAS Google Scholar
• Dai, Z., Nasr, I. W., Reel, M., Deng, S., Diggs, L., Larsen, C. P., Rothstein, D. M., & Lakkis, F. G. (2005). Impaired recall of CD8 memory T cells in immunologically privileged tissue. Journal of Immunology, 174, 1165–1170.
  CAS Google Scholar
• Das, P., Murphy, M. P., Younkin, L. H., Younkin, S. G., & Golde, T. E. (2001). Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiology of Aging, 22, 721–727.
  PubMed CAS Google Scholar
• DeSilva, D. R., Feeser, W. S., Tancula, E. J., & Scherle, P. A. (1996). Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways. The Journal of Experimental Medicine, 183, 2017–2023.
  PubMed CAS Google Scholar
• DeSilva, D. R., Jones, E. A., Feeser, W. S., Manos, E. J., & Scherle, P. A. (1997). The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells. Cellular Immunology, 180, 116–123.
  PubMed CAS Google Scholar
• Dorszewska, J., Florczak, J., Rozycka, A., Jaroszewska-Kolecka, J., Trzeciak, W. H., & Kozubski, W. (2005). Polymorphisms of the CHRNA4 gene encoding the alpha4 subunit of nicotinic acetylcholine receptor as related to the oxidative DNA damage and the level of apoptotic proteins in lymphocytes of the patients with Alzheimer’s disease. DNA and Cell Biology, 24, 786–794.
  PubMed CAS Google Scholar
• Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C. M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., Morgan, D., Gordon, M. N., Holcomb, L., Refolo, L., Zenk, B., Hardy, J., & Younkin, S. (1996). Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature, 383, 710–713.
  PubMed CAS Google Scholar
• Ebstein, R. P., Nemanov, L., Lubarski, G., Dano, M., Trevis, T., & Korczyn, A. D. (1996). Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer’s disease. Brain Research. Molecular Brain Research, 35, 260–268.
  PubMed CAS Google Scholar
• Eckert, A., Forstl, H., Hartmann, H., Czech, C., Monning, U., Beyreuther, K., & Muller, W. E. (1995). The amplifying effect of beta-amyloid on cellular calcium signalling is reduced in Alzheimer’s disease. Neuroreport, 6, 1199–1202.
  PubMed CAS Google Scholar
• Eckert, A., Oster, M., Zerfass, R., Hennerici, M., & Muller, W. E. (2001a). Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer’s disease. Specific differences to vascular dementia. Dementia and Geriatric Cognitive Disorders, 12, 98–105.
  PubMed CAS Google Scholar
• Eckert, A., Schindowski, K., Leutner, S., Luckhaus, C., Touchet, N., Czech, C., & Muller, W. E. (2001b). Alzheimer’s disease-like alterations in peripheral cells from presenilin-1 transgenic mice. Neurobiology of Disease, 8, 331–342.
  PubMed CAS Google Scholar
• Eisenbraun, M. D., Tamir, A., & Miller, R. A. (2000). Altered composition of the immunological synapse in an anergic, age-dependent memory T cell subset. Journal of Immunology, 164, 6105–6112.
  CAS Google Scholar
• Engelhardt, B., & Ransohoff, R. M. (2005). The ins and outs of T-lymphocyte trafficking to the CNS: Anatomical sites and molecular mechanisms. Trends in Immunology, 26, 485–495.
  PubMed CAS Google Scholar
• Esplugues, E., Sancho, D., Vega-Ramos, J., Martinez, C., Syrbe, U., Hamann, A., Engel, P., Sanchez-Madrid, F., & Lauzurica, P. (2003). Enhanced antitumor immunity in mice deficient in CD69. The Journal of Experimental Medicine, 197, 1093–1106.
  PubMed CAS Google Scholar
• Fiala, M., Liu, Q. N., Sayre, J., Pop, V., Brahmandam, V., Graves, M. C., & Vinters, H. V. (2002). Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier. European Journal of Clinical Investigation, 32, 360–371.
  PubMed CAS Google Scholar
• Fields, P. E., Gajewski, T. F., & Fitch, F. W. (1996). Blocked Ras activation in anergic CD4+ T cells. Science, 271, 1276–1278.
  PubMed CAS Google Scholar
• Ford, A. L., Foulcher, E., Lemckert, F. A., & Sedgwick, J. D. (1996). Microglia induce CD4 T lymphocyte final effector function and death. The Journal of Experimental Medicine, 184, 1737–1745.
  PubMed CAS Google Scholar
• Frey, C., Bonert, A., Kratzsch, T., Rexroth, G., Rosch, W., Muller-Spahn, F., Maurer, K., Muller, W. E., & Eckert, A. (2006). Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer’s disease. Journal of Neural Transmission.
• Furlan, R., Brambilla, E., Sanvito, F., Roccatagliata, L., Olivieri, S., Bergami, A., Pluchino, S., Uccelli, A., Comi, G., & Martino, G. (2003). Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain, 126, 285–291.
  PubMed Google Scholar
• Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Venturelli, E., Pijnenburg, Y. A., Bresolin, N., & Scarpini, E. (2006). Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration. Neurology, 66, 146–147.
  PubMed CAS Google Scholar
• Gee, J. R., & Keller, J. N. (2005). Astrocytes: Regulation of brain homeostasis via apolipoprotein E. The International Journal of Biochemistry and Cell Biology, 37, 1145–1150.
  CAS Google Scholar
• Geginat, J., Lanzavecchia, A., & Sallusto, F. (2003). Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines. Blood, 101, 4260–4266.
  PubMed CAS Google Scholar
• Gilman, S., Koller, M., Black, R. S., Jenkins, L., Griffith, S. G., Fox, N. C., Eisner, L., Kirby, L., Rovira, M. B., Forette, F., & Orgogozo, J. M. (2005). Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology, 64, 1553–1562.
  PubMed CAS Google Scholar
• Giuliani, F., Goodyer, C. G., Antel, J. P., & Yong, V. W. (2003). Vulnerability of human neurons to T cell-mediated cytotoxicity. Journal of Immunology, 171, 368–379.
  CAS Google Scholar
• Grossmann, A., Kukull, W. A., Jinneman, J. C., Bird, T. D., Villacres, E. C., Larson, E. B., & Rabinovitch, P. S. (1993). Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer’s disease and in older persons with Down’s syndrome. Neurobiology of Aging, 14, 177–185.
  PubMed CAS Google Scholar
• Guidi, L., Tricerri, A., Frasca, D., Vangeli, M., Errani, A. R., & Bartoloni, C. (1998). Psychoneuroimmunology and aging. Gerontology, 44, 247–261.
  PubMed CAS Google Scholar
• Hanisch, U. K., Neuhaus, J., Quirion, R., & Kettenmann, H. (1996). Neurotoxicity induced by interleukin-2: Involvement of infiltrating immune cells. Synapse, 24, 104–114.
  PubMed CAS Google Scholar
• Havenith, C. E., Askew, D., & Walker, W. S. (1998). Mouse resident microglia: Isolation and characterization of immunoregulatory properties with naive CD4+ and CD8+ T-cells. Glia, 22, 348–359.
  PubMed CAS Google Scholar
• Hubert, P., Grenot, P., Autran, B., & Debre, P. (1997). Analysis by flow cytometry of tyrosine-phosphorylated proteins in activated T-cell subsets on whole blood samples. Cytometry, 29, 83–91.
  PubMed CAS Google Scholar
• Iarlori, C., Gambi, D., Gambi, F., Lucci, I., Feliciani, C., Salvatore, M., & Reale, M. (2005). Expression and production of two selected beta-chemokines in peripheral blood mononuclear cells from patients with Alzheimer’s disease. Experimental Gerontology, 40, 605–611.
  PubMed CAS Google Scholar
• Ibarreta, D., Parrilla, R., & Ayuso, M. S. (1997). Altered Ca2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. Alzheimer Disease and Associated Disorders, 11, 220–227.
  PubMed CAS Google Scholar
• Ikeda, T., Yamamoto, K., Takahashi, K., Kaneyuki, H., & Yamada, M. (1991a). Interleukin-2 receptor in peripheral blood lymphocytes of Alzheimer’s disease patients. Acta Psychiatrica Scandinavica, 84, 262–265.
  PubMed CAS Google Scholar
• Ikeda, T., Yamamoto, K., Takahashi, K., & Yamada, M. (1991b). Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with Alzheimer’s disease. Acta Psychiatrica Scandinavica, 83, 444–448.
  PubMed CAS Google Scholar
• Itagaki, S., McGeer, P. L., & Akiyama, H. (1988). Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer’s disease brain tissue. Neuroscience Letters, 91, 259–264.
  PubMed CAS Google Scholar
• Jang, I. K., & Gu, H. (2003). Negative regulation of TCR signaling and T-cell activation by selective protein degradation. Current Opinion in Immunology, 15, 315–320.
  PubMed CAS Google Scholar
• Lassmann, H., & Ransohoff, R. M. (2004). The CD4-Th1 model for multiple sclerosis: A critical [correction of crucial] re-appraisal. Trends in Immunology, 25, 132–137.
  PubMed CAS Google Scholar
• Ledoux, S., Rebai, N., Dagenais, A., Shaw, I. T., Nalbantoglu, J., Sekaly, R. P., & Cashman, N. R. (1993). Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. Journal of Immunology, 150, 5566–5575.
  CAS Google Scholar
• Lemere, C. A., Maron, R., Selkoe, D. J., & Weiner, H. L. (2001). Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer’s disease. DNA and Cell Biology, 20, 705–711.
  PubMed CAS Google Scholar
• Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., Desai, R., Hancock, W. W., Weiner, H. L., & Selkoe, D. J. (2000). Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice. Annals of the New York Academy of Sciences, 920, 328–331.
  Article PubMed CAS Google Scholar
• Leutner, S., Czech, C., Schindowski, K., Touchet, N., Eckert, A., & Muller, W. E. (2000). Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations. Neuroscience Letters, 292, 87–90.
  PubMed CAS Google Scholar
• Ligthart, G. J., Corberand, J. X., Fournier, C., Galanaud, P., Hijmans, W., Kennes, B., Muller-Hermelink, H. K., & Steinmann, G. G. (1984). Admission criteria for immunogerontological studies in man: The SENIEUR protocol. Mechanisms of Ageing and Development, 28, 47–55.
  PubMed CAS Google Scholar
• Lombardi, V. R., Garcia, M., Rey, L., & Cacabelos, R. (1999). Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer’s Disease (AD) individuals. Journal of Neuroimmunology, 97, 163–171.
  PubMed CAS Google Scholar
• Maesaka, J. K., Palaia, T., Chowdhury, S. A., Shimamura, T., Fishbane, S., Reichman, W., Coyne, A., O’Rear, J. J., & El-Sabban, M. E. (1999). Partial characterization of apoptotic factor in Alzheimer plasma. The American Journal of Physiology, 276, F521–527.
  PubMed CAS Google Scholar
• Masliah, E., Hansen, L., Adame, A., Crews, L., Bard, F., Lee, C., Seubert, P., Games, D., Kirby, L., & Schenk, D. (2005). Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology, 64, 129–131.
  PubMed CAS Google Scholar
• Matyszak, M. K., Denis-Donini, S., Citterio, S., Longhi, R., Granucci, F., & Ricciardi-Castagnoli, P. (1999). Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. European Journal of Immunology, 29, 3063–3076.
  PubMed CAS Google Scholar
• McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989). Immune system response in Alzheimer’s disease. The Canadian Journal of Neurological Sciences, 16, 516–527.
  PubMed CAS Google Scholar
• Mirshahidi, S., Ferris, L. C., & Sadegh-Nasseri, S. (2004). The magnitude of TCR engagement is a critical predictor of T cell anergy or activation. Journal of Immunology, 172, 5346–5355.
  CAS Google Scholar
• Mirshahidi, S., Huang, C. T., & Sadegh-Nasseri, S. (2001). Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor. The Journal of Experimental Medicine, 194, 719–731.
  PubMed CAS Google Scholar
• Monning, U., Konig, G., Banati, R. B., Mechler, H., Czech, C., Gehrmann, J., Schreiter-Gasser, U., Masters, C. L., & Beyreuther, K. (1992). Alzheimer beta A4-amyloid protein precursor in immunocompetent cells. The Journal of Biological Chemistry, 267, 23950–23956.
  PubMed CAS Google Scholar
• Monsonego, A., Maron, R., Zota, V., Selkoe, D. J., & Weiner, H. L. (2001). Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: Implications for the pathogenesis and treatment of Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 98, 10273–10278.
  PubMed CAS Google Scholar
• Monsonego, A., Zota, V., Karni, A., Krieger, J. I., Bar-Or, A., Bitan, G., Budson, A. E., Sperling, R., Selkoe, D. J., & Weiner, H. L. (2003). Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. The Journal of Clinical Investigation, 112, 415–422.
  PubMed CAS Google Scholar
• Orgogozo, J. M., Gilman, S., Dartigues, J. F., Laurent, B., Puel, M., Kirby, L. C., Jouanny, P., Dubois, B., Eisner, L., Flitman, S., Michel, B. F., Boada, M., Frank, A., & Hock, C. (2003). Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology, 61, 46–54.
  PubMed CAS Google Scholar
• Palotas, A., Kalman, J., Palotas, M., Juhasz, A., Janka, Z., & Penke, B. (2002). Beta-amyloid-induced increase in the resting intracellular calcium concentration gives support to tell Alzheimer lymphocytes from control ones. Brain Research Bulletin, 58, 203–205.
  PubMed CAS Google Scholar
• Panossian, L. A., Porter, V. R., Valenzuela, H. F., Zhu, X., Reback, E., Masterman, D., Cummings, J. L., & Effros, R. B. (2003). Telomere shortening in T cells correlates with Alzheimer’s disease status. Neurobiology of Aging, 24, 77–84.
  PubMed CAS Google Scholar
• Park, E., Alberti, J., Mehta, P., Dalton, A., Sersen, E., & Schuller-Levis, G. (2000). Partial impairment of immune functions in peripheral blood leukocytes from aged men with Down’s syndrome. Clinical Immunology, 95, 62–69.
  PubMed CAS Google Scholar
• Pirttila, T., Mattinen, S., & Frey, H. (1992). The decrease of CD8-positive lymphocytes in Alzheimer’s disease. Journal of Neurological Sciences, 107, 160–165.
  CAS Google Scholar
• Ratts, R. B., Karandikar, N. J., Hussain, R. Z., Choy, J., Northrop, S. C., Lovett-Racke, A. E., & Racke, M. K. (2006). Phenotypic characterization of autoreactive T cells in multiple sclerosis. Journal of Neuroimmunology, 178, 100–110.
  PubMed CAS Google Scholar
• Robinson Agramonte, M., Dorta-Contreras, A. J., & Lorigados Pedre, L. (2001). Immune events in central nervous system of early and late onset Alzheimer’s disease patients. Revista de Neurologia, 32, 901–904.
  PubMed CAS Google Scholar
• Rogers, J., & Mufson, E. J. (1990). Demonstrating immune-related antigens in Alzheimer’s disease brain tissue. Neurobiology of Aging, 11, 477–479.
  PubMed CAS Google Scholar
• Rota, E., Bellone, G., Rocca, P., Bergamasco, B., Emanuelli, G., & Ferrero, P. (2006). Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer’s disease patients. Neurological Sciences, 27, 33–39.
  PubMed CAS Google Scholar
• Rubin, B., Llobera, R., Gouaillard, C., Alcover, A., & Arnaud, J. (2000). Dissection of the role of CD3gamma chains in profound but reversible T-cell receptor down-regulation. Scandinavian Journal of Immunology, 52, 173–183.
  PubMed CAS Google Scholar
• Sala, G., Galimberti, G., Canevari, C., Raggi, M. E., Isella, V., Facheris, M., Appollonio, I., & Ferrarese, C. (2003). Peripheral cytokine release in Alzheimer patients: Correlation with disease severity. Neurobiology of Aging, 24, 909–914.
  PubMed CAS Google Scholar
• Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., & Seubert, P. (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173–177.
  PubMed CAS Google Scholar
• Schindowski, K., Frohlich, L., Maurer, K., Muller, W. E., & Eckert, A. (2002). Age-related impairment of human T lymphocytes’ activation: Specific differences between CD4(+) and CD8(+) subsets. Mechanisms of Ageing and Development, 123, 375–390.
  PubMed CAS Google Scholar
• Schindowski, K., Kratzsch, T., Peters, J., Steiner, B., Leutner, S., Touchet, N., Maurer, K., Czech, C., Pradier, L., Frolich, L., Muller, W. E., & Eckert, A. (2003). Impact of aging: Sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer’s disease. Neuromolecular Medicine, 4, 161–178.
  PubMed CAS Google Scholar
• Schindowski, K., Leutner, S., Muller, W. E., & Eckert, A. (2000). Age-related changes of apoptotic cell death in human lymphocytes. Neurobiology of Aging, 21, 661–670.
  PubMed CAS Google Scholar
• Schindowski, K., Peters, J., Gorriz, C., Schramm, U., Weinandi, T., Leutner, S., Maurer, K., Frölich, L., Muller, W. E., & Eckert, A. (2006). Apoptosis of CD4+ T and natural killer cells in Alzheimer’s disease. Pharmacopsychiatry, 39, 220–228.
  PubMed CAS Google Scholar
• Schlunck, T., Schraut, W., Riethmuller, G., & Ziegler-Heitbrock, H. W. (1990). Inverse relationship of CA2+ mobilization and cell proliferation in CD8+ memory and virgin T cells. European Journal of Immunology, 20, 1957–1963.
  PubMed CAS Google Scholar
• Schmid, I., Uittenbogaart, C. H., Keld, B., & Giorgi, J. V. (1994). A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry. Journal of Immunological Methods, 170, 145–157.
  PubMed CAS Google Scholar
• Schuessel, K., Schafer, S., Bayer, T. A., Czech, C., Pradier, L., Muller-Spahn, F., Muller, W. E., & Eckert, A. (2005). Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiology of Disease, 18, 89–99.
  PubMed CAS Google Scholar
• Seabrook, T. J., Thomas, K., Jiang, L., Bloom, J., Spooner, E., Maier, M., Bitan, G., & Lemere, C. A. (2007). Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice. Neurobiology of Aging, 28, 813–823.
  PubMed CAS Google Scholar
• Sedgwick, J. D., Mossner, R., Schwender, S., & ter Meulen, V. (1991). Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: Astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system. Journal of Experimental Medicine, 173, 1235–1246.
  PubMed CAS Google Scholar
• Shalit, F., Sredni, B., Brodie, C., Kott, E., & Huberman, M. (1995). T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer’s disease. Clinical Immunology and Immunopathology, 75, 246–250.
  PubMed CAS Google Scholar
• Singh, V. K. (1990). Neuroimmune axis as a basis of therapy in Alzheimer’s disease. Progress in Drug Research, 34, 383–393.
  PubMed CAS Google Scholar
• Stieler, J. T., Lederer, C., Bruckner, M. K., Wolf, H., Holzer, M., Gertz, H. J., & Arendt, T. (2001). Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer’s disease. Neuroreport, 12, 3969–3972.
  PubMed CAS Google Scholar
• Tan, J., Town, T., Abdullah, L., Wu, Y., Placzek, A., Small, B., Kroeger, J., Crawford, F., Richards, D., & Mullan, M. (2002). CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer’s disease. Journal of Neuroimmunology, 132, 164–172.
  PubMed CAS Google Scholar
• Tanchot, C., Rosado, M. M., Agenes, F., Freitas, A. A., & Rocha, B. (1997). Lymphocyte homeostasis. Seminars in Immunology, 9, 331–337.
  PubMed CAS Google Scholar
• Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K., & Kosaka, K. (2002). Occurrence of T cells in the brain of Alzheimer’s disease and other neurological diseases. Journal of Neuroimmunology, 124, 83–92.
  PubMed CAS Google Scholar
• Torres, P. S., Alcover, A., Zapata, D. A., Arnaud, J., Pacheco, A., Martin-Fernandez, J. M., Villasevil, E. M., Sanal, O., & Regueiro, J. R. (2003). TCR dynamics in human mature T lymphocytes lacking CD3 gamma. Journal of Immunology, 170, 5947–5955.
  CAS Google Scholar
• Town, T., Tan, J., Flavell, R. A., & Mullan, M. (2005). T-cells in Alzheimer’s disease. Neuromolecular Medicine, 7, 255–264.
  PubMed CAS Google Scholar
• Town, T., Tan, J., Sansone, N., Obregon, D., Klein, T., & Mullan, M. (2001). Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42. Neuroscience Letters, 307, 101–104.
  PubMed CAS Google Scholar
• Town, T., Vendrame, M., Patel, A., Poetter, D., DelleDonne, A., Mori, T., Smeed, R., Crawford, F., Klein, T., Tan, J., & Mullan, M. (2002). Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer’s beta-amyloid(1-42). Journal of Neuroimmunology, 132, 49–59.
  PubMed CAS Google Scholar
• Trieb, K., Ransmayr, G., Sgonc, R., Lassmann, H., & Grubeck-Loebenstein, B. (1996). APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer’s disease. Neurobiology of Aging, 17, 541–547.
  PubMed CAS Google Scholar
• Valitutti, S., Muller, S., Cella, M., Padovan, E., & Lanzavecchia, A. (1995). Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature, 375, 148–151.
  PubMed CAS Google Scholar
• Vingtdeux, V., Hamdane, M., Gompel, M., Begard, S., Drobecq, H., Ghestem, A., Grosjean, M. E., Kostanjevecki, V., Grognet, P., Vanmechelen, E., Buee, L., Delacourte, A., & Sergeant, N. (2005). Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiology of Disease, 20, 625–637.
  PubMed CAS Google Scholar
• Weishaupt, A., Jander, S., Bruck, W., Kuhlmann, T., Stienekemeier, M., Hartung, T., Toyka, K. V., Stoll, G., & Gold, R. (2000). Molecular mechanisms of high-dose antigen therapy in experimental autoimmune encephalomyelitis: Rapid induction of Th1-type cytokines and inducible nitric oxide synthase. Journal of Immunology, 165, 7157–7163.
  CAS Google Scholar
• Wenham, P. R., Price, W. H., & Blandell, G. (1991). Apolipoprotein E genotyping by one-stage PCR. Lancet, 337, 1158–1159.
  PubMed CAS Google Scholar
• Zhang, J., Kong, Q., Zhang, Z., Ge, P., Ba, D., & He, W. (2003). Telomere dysfunction of lymphocytes in patients with Alzheimer disease. Cognitive and Behavirol Neurology, 16, 170–176.
  Google Scholar

Download references